Caremax Inc (CMAX)

$2.89 0.12 (4.33%)

16:00 EDT CMAX Stock Quote Delayed 30 Minutes

CMAX Stock Earnings: CareMax Misses EPS, Beats Revenue for Q1 2024

By InvestorPlace Earnings May 9, 2024

CMAX stock results show that CareMax missed analyst estimates for earnings per share but beat on revenue for the first quarter of 2024.

3 Stocks That Are Actually Worth Shorting for Endless Gains

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday

CMAX Stock Earnings: CareMax Beats EPS, Misses Revenue for Q4 2023

More Articles

Volume:

Previous Close -

Market Cap -

PE Ratio -

EPS -

Volume (Avg. Vol.) 16,060

Day's Range $2.70 - $2.99

52-Week Range $0.30 - $16.32

Dividend & Yield N/A (N/A)

CMAX Stock Predictions, Articles, and Caremax Inc News

From the Web

CareMax announces 1-for-30 reverse stock split of its class A common stock (NASDAQ:CMAX)

From Seeking Alpha Jan 29, 2024

CareMax (CMAX) has approved a 1-for-30 reverse stock split in order to regain compliance with Nasdaq's minimum bid price rule and maintain its listing.

CareMax GAAP EPS of -$0.29 misses by $0.24, revenue of $224.4M beats by $40.13M (NASDAQ:CMAX)

From Seeking Alpha Aug 9, 2023

CareMax press release (CMAX): Q2 GAAP EPS of -$0.29 misses by $0.24.Revenue of $224.4M (+30.3% Y/Y) beats by $40.13M.Total membership of 272,500, up 210%...

CareMax EPS of -$0.74, revenue of $172.98M misses by $5.75M (NASDAQ:CMAX)

From Seeking Alpha May 10, 2023

CareMax press release (CMAX): Q1 EPS of -$0.74 may not be comparable to consensus of -$0.04.Revenue of $172.98M (+26.3% Y/Y) misses by $5.75M.Total Value-Based Care membership of...

CareMax downgraded at Cowen on full risk, EBITDA struggles

From Seeking Alpha Mar 17, 2023

Cowen has downgraded CareMax (CMAX) to market perform from outperform saying that plans to boost full-risk lives and improve EBITDA could prove challenging. Read more here.

CareMax GAAP EPS of $0.10 beats by $0.15, revenue of $164.26M beats by $13.65M (NASDAQ:CMAX)

From Seeking Alpha Mar 9, 2023

CareMax press release (CMAX): Q4 GAAP EPS of $0.10 beats by $0.15.Revenue of $164.26M (+38.9% Y/Y) beats by $13.65M.Adjusted EBITDA (including the impact of de novo pre-opening...

OSH stock upgraded at Raymond James on CVS takeover interest (NYSE:OSH)

From Seeking Alpha Jan 12, 2023

Raymond James upgraded primary care service provider Oak Street Health (OSH) on Thursday, citing its potential to draw takeover interest from CVS (CVS). Read the full story here.

ADVERTISEMENT